LONG TERM DISEASE CONTROL WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/ REFRACTORY MULTIPLE MYELOMA PATIENTS: A REAL LIFE EXPERIENCE

被引：0
|
作者：
Parisi, M. [1 ]
Conticello, C. [1 ]
Leotta, S. [1 ]
Martino, E. [1 ]
Calafiore, V [1 ]
Del Fabro, V [1 ]
Pirosa, M. C. [1 ]
Romano, A. [1 ]
Di Raimondo, F. [1 ]
机构：
[1] Univ Catania, Div Hematol, AO Policlin Vittorio Emanuele, Catania, Italy
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P51
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [41] Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma
    Garderet, Laurent
    Kuhnowski, Frederique
    Berge, Benoit
    Roussel, Murielle
    Escoffre-Barbe, Martine
    Lafon, Ingrid
    Facon, Thierry
    Leleu, Xavier
    Karlin, Lionel
    Perrot, Aurore
    Moreau, Philippe
    Marit, Gerald
    Stoppa, Anne-Marie
    Royer, Bruno
    Chaleteix, Carine
    Tiab, Mourad
    Araujo, Carla
    Lenain, Pascal
    Macro, Margaret
    Voog, Eric
    Benboubker, Lofti
    Allangba, Olivier
    Jourdan, Eric
    Orsini-Piocelle, Frederique
    Brechignac, Sabine
    Eveillard, Jean-Richard
    Belhadj, Karim
    Wetterwald, Marc
    Pegourie, Brigitte
    Jaccard, Arnaud
    Eisenmann, Jean-Claude
    Glaisner, Sylvie
    Mohty, Mohamad
    Hulin, Cyrille
    Avet-Loiseau, Herve
    Mathiot, Claire
    Attal, Michel
    BLOOD, 2018, 132 (24) : 2555 - 2563
  • [42] Selinexor Plus Pomalidomide and Low Dose Dexamethasone (SPd) in Patients with Relapsed or Refractory Multiple Myeloma
    Chen, Christine I.
    Sutherland, Heather J.
    Kotb, Rami
    Sebag, Michael
    White, Darrell J.
    Bensinger, William
    Gasparetto, Cristina J.
    Leblanc, Richard
    Venner, Christopher P.
    Lentzsch, Suzanne
    Schiller, Gary J.
    Lipe, Brea
    Del Col, Aldo
    Shah, Jatin J.
    Jeha, Jacqueline
    Saint-Martin, Jean-Richard
    Kauffman, Michael G.
    Shacham, Sharon
    Bahlis, Nizar
    BLOOD, 2018, 132
  • [43] Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/ Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience
    Rodriguez-Otero, Paula
    Sirvent, Maialen
    Pilar Gonzalez-Rodriguez, Ana
    Lavilla, Esperanza
    Garcia de Coca, Alfonso
    Maria Arguinano, Jose
    Marti, Josep M.
    Cabanas, Valentin
    Motllo, Cristina
    de Cabo, Erik
    Encinas, Cristina
    Murillo, Ilda
    Angel Hernandez-Rivas, Jose
    Perez-Persona, Ernesto
    Casado, Felipe
    Sampol, Antonia
    Garcia, Ricarda
    Jesus Blanchard, Maria
    Anguita, Magdalena
    Paz Lafuente, Ana
    Inigo, Belen
    Lopez, Aurelio
    Ribas, Paz
    Arnao, Mario
    Maldonado, Roberto
    Blade, Joan
    Victoria Mateos, Maria
    Jose Lahuerta, Juan
    San Miguel, Jesus F.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 413 - 420
  • [44] Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma
    Cohen, Alexa
    Spektor, Tanya M.
    Stampleman, Laura
    Bessudo, Alberto
    Rosen, Peter J.
    Klein, Leonard M.
    Woliver, Thomas
    Flam, Marshall
    Eshaghian, Shahrooz
    Nassir, Youram
    Maluso, Tina
    Swift, Regina A.
    Vescio, Robert
    Berenson, James R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (01) : 60 - 70
  • [45] A phase 2 trial of leflunomide, pomalidomide, and dexamethasone for relapsed/refractory multiple myeloma
    Rosenzweig, Michael
    Sanchez, James
    Chowdhury, Arnab
    Nathwani, Nitya
    Janakiram, Murali
    Htut, Myo
    Sahebi, Firoozeh
    Walker, Tricia
    Pichiorri, Flavia
    Palmer, Joycelynne
    Krishnan, Amrita
    Keats, Jonathan
    Rosen, Steven
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S153 - S153
  • [46] Selinexor in Combination with Pomalidomide and Dexamethasone (SPd) for Treatment of Patients with Relapsed Refractory Multiple Myeloma (RRMM)
    Chen, Christine I.
    Bahlis, Nizar J.
    Gasparetto, Cristina
    Tuchman, Sascha A.
    Lipe, Brea
    Baljevic, Muhamed
    Kotb, Rami
    Sutherland, Heather J.
    Bensinger, William I.
    Sebag, Michael
    LeBlanc, Richard
    Venner, Christopher P.
    Schiller, Gary J.
    Lentzsch, Suzanne
    Callander, Natalie S.
    Rossi, Adriana C.
    Sheehan, Heidi
    Van Domelen, Dane
    Kazuharu, Kai
    Wang, Hongwei
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    White, Darrell J.
    BLOOD, 2020, 136
  • [47] Daratumumab Combined with Pomalidomide and Dexamethasone (DPd) for Patients with Relapsed/Refractory Multiple Myeloma in a Single Institution
    Abdallah, Al-Ola
    McGuirk, Joseph P.
    Shune, Leyla
    Dunavin, Neil
    Mahmoudjafari, Zahra
    Hochard, Erica
    Ganguly, Siddhartha
    BLOOD, 2017, 130
  • [48] Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
    Siegel, David S.
    Schiller, Gary J.
    Samaras, Christy
    Sebag, Michael
    Berdeja, Jesus
    Ganguly, Siddhartha
    Matous, Jeffrey
    Song, Kevin
    Seet, Christopher S.
    Talamo, Giampaolo
    Acosta-Rivera, Mirelis
    Bar, Michael
    Quick, Donald
    Anz, Bertrand
    Fonseca, Gustavo
    Reece, Donna
    Pierceall, William E.
    Chung, Weiyuan
    Zafar, Faiza
    Agarwal, Amit
    Bahlis, Nizar J.
    LEUKEMIA, 2020, 34 (12) : 3286 - 3297
  • [49] Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma
    Richardson, Paul G.
    Facon, Thierry
    Bensinger, William I.
    Leleu, Xavier
    Campana, Frank
    Mace, Sandrine
    Chiron, Marielle
    van de Velde, Helgi
    Mikhael, Joseph
    BLOOD CANCER JOURNAL, 2021, 11 (03)
  • [50] Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma
    Badros, Ashraf
    Hyjek, Elizabeth
    Ma, Ning
    Lesokhin, Alexander
    Dogan, Ahmet
    Rapoport, Aaron P.
    Kocoglu, Mehmet
    Lederer, Emily
    Philip, Sunita
    Milliron, Todd
    Dell, Cameron
    Goloubeva, Olga
    Singh, Zeba
    BLOOD, 2017, 130 (10) : 1189 - 1197
12345